Sevoflurane is an ether inhalation anesthetic agent used to induce and maintain general anesthesia. It is a volatile, non-flammable compound with a low solubility profile and blood/gas partition coefficient. Sevoflurane was patented in 1972, was approved for clinical use in Japan in 1990, and approved by the FDA in 1996. Sevoflurane is three times more poten...
Sevoflurane is used for the induction and maintenance of general anesthesia in adult and pediatric patients for inpatient and outpatient surgery.
London Health Sciences Centre, London, Ontario, Canada
Kaohsiung Medical University Chung-Ho Memorial Hospital, Kaohsiung, Taiwan
Peking Union Medical College Hospital, Beijing, Beijing, China
Bekzat, Astana, Kazakhstan
Bekzat, Astana, Kazakhstan
Bekzat, Astana, Kazakhstan
Bekzat, Astana, Kazakhstan
Kaohsiung Medical University Chung-Ho Memorial Hospital, Kaohsiung, Taiwan
Alexandria University Faculty of Medicin, Alexandria, Egypt
Tumor Hospital of Jiangxi Province, Nanchang, Jiangxi, China
People's Hospital of Ganzhou, Ganzhou, Jiangxi, China
the First Affiliated Hospital of Gannan Medical College, Gannan Medical College, Ganzhou, Jiangxi, China
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.